APA (7th ed.) Citation

Gulbanu Sarsenbayeva, Timur Issagulov, Markhabat Kassenov, Ruslan Abitay, Mukhit Orynbayev, Marina Stukova, . . . Berik Khairullin. (2020). Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: A phase II, a randomized, comparative trial in Kazakhstan. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Gulbanu Sarsenbayeva, et al. Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Adults 60 Years of Age and Older: A Phase II, a Randomized, Comparative Trial in Kazakhstan. Taylor & Francis Group, 2020.

MLA (9th ed.) Citation

Gulbanu Sarsenbayeva, et al. Safety and Immunogenicity of Trivalent Inactivated Influenza Vaccine in Adults 60 Years of Age and Older: A Phase II, a Randomized, Comparative Trial in Kazakhstan. Taylor & Francis Group, 2020.